NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Nivolumab for previously treated advanced renal cell carcinoma - NICE TAG TA417

Nivolumab for previously treated advanced renal cell carcinoma - NICE TAG TA417

1.1 Nivolumab is recommended, within its marketing authorisation, as an option for previously treated advanced renal cell carcinoma in adults, when the company provides nivolumab with the discount agreed in the patient access scheme.

https://www.nice.org.uk/guidance/ta417

Site by Devopa
© Copyright 2021 NHS. All rights reserved.